Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. D-gal
2. D-galactopyranose
3. D-galactopyranoside
4. Gal
5. Galactopyranose
6. Galactopyranoside
7. Galactose
8. 10257-28-0
9. (3r,4s,5r,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
10. Chebi:4139
11. Cerebrose
12. (+)-galactose
13. D-glucose-2-13c
14. 40825-89-6
15. Smr000857326
16. Nsc-8102
17. Ncgc00159442-02
18. Einecs 233-595-2
19. D-galactose (9ci)
20. Dsstox_cid_3088
21. Galactose, D- (8ci)
22. Epitope Id:141794
23. D-(+)-galactose Anhydrous
24. Dsstox_rid_76869
25. Dsstox_gsid_23088
26. Schembl38935
27. Mls001335983
28. Mls001335984
29. Chembl195923
30. (3r,4s,5r,6r)-6-(hydroxymethyl)tetrahydro-2h-pyran-2,3,4,5-tetraol
31. Bdbm228805
32. Dtxsid001015860
33. Hms2230n07
34. Nsc 8102
35. Tox21_111672
36. Mfcd00006969
37. S3849
38. Akos030573864
39. Ccg-266426
40. Cas-59-23-4
41. D-galactose Plant Origin (ex Peach Gum)
42. Ncgc00166082-01
43. As-46931
44. Cs-0204480
45. G0008
46. C00124
47. D-galactose 1000 Microg/ml In Methanol:water
48. F10950
49. G-1701
50. O_full_10000000000000_gs_94
51. Q27106307
52. (3r,4s,5r,6r)-6-methyloltetrahydropyran-2,3,4,5-tetrol
53. Wurcs=2.0/1,1,0/[a2112h-1x_1-5]/1/
| Molecular Weight | 180.16 g/mol |
|---|---|
| Molecular Formula | C6H12O6 |
| XLogP3 | -2.6 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Exact Mass | 180.06338810 g/mol |
| Monoisotopic Mass | 180.06338810 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 151 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
V - Various
V04 - Diagnostic agents
V04C - Other diagnostic agents
V04CE - Tests for liver functional capacity
V04CE01 - Galactose
ABOUT THIS PAGE
A D-Galactopyranose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D-Galactopyranose, including repackagers and relabelers. The FDA regulates D-Galactopyranose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D-Galactopyranose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A D-Galactopyranose supplier is an individual or a company that provides D-Galactopyranose active pharmaceutical ingredient (API) or D-Galactopyranose finished formulations upon request. The D-Galactopyranose suppliers may include D-Galactopyranose API manufacturers, exporters, distributors and traders.
D-Galactopyranose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D-Galactopyranose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right D-Galactopyranose GMP manufacturer or D-Galactopyranose GMP API supplier for your needs.
A D-Galactopyranose CoA (Certificate of Analysis) is a formal document that attests to D-Galactopyranose's compliance with D-Galactopyranose specifications and serves as a tool for batch-level quality control.
D-Galactopyranose CoA mostly includes findings from lab analyses of a specific batch. For each D-Galactopyranose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D-Galactopyranose may be tested according to a variety of international standards, such as European Pharmacopoeia (D-Galactopyranose EP), D-Galactopyranose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D-Galactopyranose USP).
LOOKING FOR A SUPPLIER?
